- Report
- March 2024
- 196 Pages
Global
From €3237EUR$3,374USD£2,788GBP
€3597EUR$3,749USD£3,098GBP
- Report
- October 2023
- 188 Pages
Global
From €4701EUR$4,900USD£4,049GBP
The Marine Derived Drug market is a subset of the biopharmaceutical industry, which focuses on the development and commercialization of drugs derived from marine organisms. These drugs are typically derived from marine organisms such as bacteria, fungi, algae, and invertebrates, and are used to treat a variety of diseases and conditions. Marine derived drugs are often used to treat cancer, infectious diseases, and neurological disorders.
The Marine Derived Drug market is highly competitive, with many companies vying for a share of the market. Companies in the market include Amgen, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more